Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

cancer stem cells

  • You have access
    Isolation and Biological Evaluation of Breast Cancer Side Population Cells Using DyeCycle Violet
    AYA KUMAZAKI, YUKIHIKO OSAWA, KONATSU IMANAKA, YUKI OHMOTO, MAIKA YOKOE, YUTO MASAKI, HIROKAZU ODASHIMA, TAKAFUMI ONISHI and MANABU HATTORI
    Anticancer Research May 2026, 46 (5) 2417-2427; DOI: https://doi.org/10.21873/anticanres.18127
  • You have access
    CD133+ Lung Cancer Stem-like Cells Resist Plasma-activated Medium Through PRDX5-mediated Antioxidant Defense
    NAN-NAN YU, YUE LIU, XIAO-YU GUO, KEE KWANG KIM, JI HYE KIM, TAEHO KWON, DONG HUN LEE and HU-NAN SUN
    Anticancer Research March 2026, 46 (3) 1293-1306; DOI: https://doi.org/10.21873/anticanres.18030
  • You have access
    Targeting mTOR Signaling in Cancer: The Promise of Natural Product-derived Inhibitors
    PITHI CHANVORACHOTE, CHATCHAI CHAOTHAM, ZIN ZIN EI and PREEDAKORN CHUNHACHA
    Anticancer Research February 2026, 46 (2) 553-568; DOI: https://doi.org/10.21873/anticanres.17969
  • You have access
    Isolation and Characterization of Putative Cancer Stem Cells from Oral Squamous Cell Carcinoma Cells
    ANA LAURA VALENÇA BIZELI, IARA GONÇALVES AQUINO, FLORENCE JUANA MARIA CUADRA-ZELAYA, PATRICIA VIANNA BONINI PALMA, TUULA SALO, RICARDO DELLA COLETTA, DÉBORA CAMPANELLA BASTOS and EDGARD GRANER
    Anticancer Research November 2025, 45 (11) 4803-4815; DOI: https://doi.org/10.21873/anticanres.17829
  • Open Access
    NK Cells Can Target Castration-resistant Prostate Cancer Stem Cells With the Involvement of Degranulation Pathway
    ASUKA HATTORI, TAIGA SEKI, KAZUNORI KATO, NANTIGA VIRGONA, YUICHI MIYAKOSHI, KAKERU KOHNO and TOMOHIRO YANO
    Anticancer Research August 2025, 45 (8) 3197-3207; DOI: https://doi.org/10.21873/anticanres.17682
  • Open Access
    DNA Ligase 4 Inhibition Sensitizes Prostate Cancer to Immune Checkpoint Blockade In Vivo
    JIANCHUN WU, ANGELICA M. LAGUNAS and DAVID L. CROWE
    Anticancer Research March 2025, 45 (3) 883-896; DOI: https://doi.org/10.21873/anticanres.17476
  • You have access
    CD44-positive Cancer Stem-like Cells as a Potential Source of Peritoneal Metastasis After Surgery
    ANDREAS MICHAEL SIHOMBING, SATOSHI MURATA, MIYUKI SHIMOJI, TORU MIYAKE, KATSUSHI TAKEBAYASHI, HIROKAZU KODAMA, AYA TOKUDA, MASATSUGU KOJIMA, TOMOYUKI UEKI, NAOMI KITAMURA, MINA KITAMURA, EIJI MEKATA and MASAJI TANI
    Anticancer Research June 2023, 43 (6) 2491-2500; DOI: https://doi.org/10.21873/anticanres.16416
  • You have access
    Heparanase Expression Is Associated With Cancer Stem Cell Features and Radioresistance in Hodgkin’s Lymphoma Cells
    FABIAN M. TROSCHEL, MATTHIAS LINSENMAIER, KATRIN BORRMANN, HANS THEODOR EICH, MARTIN GÖTTE and BURKHARD GREVE
    Anticancer Research July 2021, 41 (7) 3299-3308; DOI: https://doi.org/10.21873/anticanres.15117
  • You have access
    Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients
    MARIA A. PAPADAKI, DESPOINA AGGOURAKI, ELENI-KYRIAKI VETSIKA, NIKOLAOS XENIDIS, GALAKTEA KALLERGI, ATHANASIOS KOTSAKIS and VASSILIS GEORGOULIAS
    Anticancer Research February 2021, 41 (2) 661-670; DOI: https://doi.org/10.21873/anticanres.14817
  • You have access
    Molecular Targeting of H/MDM-2 Oncoprotein in Human Colon Cancer Cells and Stem-like Colonic Epithelial-derived Progenitor Cells
    ANUSHA THADI, WILLIAM F. MORANO, MARIAN KHALILI, BLAKE D. BABCOCK, MOHAMMAD F. SHAIKH, DESHKA S. FOSTER, YELENA PIAZZA, ELIZABETH M. GLEESON, EVE GOLDSTEIN, LINDSAY STEELE, PAUL M. CAMPBELL, BO LIN, MATTHEW R. PINCUS and WILBUR B. BOWNE
    Anticancer Research January 2021, 41 (1) 27-42; DOI: https://doi.org/10.21873/anticanres.14749

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire